C.M. Bidwell & Associates’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139 | Hold |
12
| – | – | ﹤0.01% | 441 |
|
|
2025
Q1 | $105 | Hold |
12
| – | – | ﹤0.01% | 437 |
|
|
2024
Q4 | $172 | Sell |
12
-60
| -83% | -$860 | ﹤0.01% | 480 |
|
|
2024
Q3 | $1.63K | Hold |
72
| – | – | ﹤0.01% | 439 |
|
|
2024
Q2 | $1.4K | Hold |
72
| – | – | ﹤0.01% | 417 |
|
|
2024
Q1 | $2.7K | Hold |
72
| – | – | ﹤0.01% | 401 |
|
|
2023
Q4 | $4.03K | Hold |
72
| – | – | ﹤0.01% | 345 |
|
|
2023
Q3 | $2.97K | Hold |
72
| – | – | ﹤0.01% | 415 |
|
|
2023
Q2 | $4.02K | Hold |
72
| – | – | ﹤0.01% | 409 |
|
|
2023
Q1 | $4.02K | Hold |
72
| – | – | ﹤0.01% | 402 |
|
|
2022
Q4 | $2.62K | Buy |
+72
| New | +$2.62K | ﹤0.01% | 414 |
|
|
2022
Q3 | – | Sell |
-12
| Closed | -$1K | – | 544 |
|
|
2022
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 478 |
|
|
2022
Q1 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 515 |
|